Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program
07 juil. 2020 09h00 HE
|
Headlands Research
SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) -- Headlands Research, a global next-generation clinical research site organization, today announced its acquisition of two large central nervous system...
ECOFIBRE LIMITED – Ananda Health products used in first FDA authorized clinical trial on hemp-derived CBD to treat chemotherapy induced peripheral neuropathy
07 juil. 2020 08h58 HE
|
Ecofibre
Georgetown, Kentucky, July 07, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...
Entera Bio Ltd Provides Update on Phase 2 Clinical Trial of EB613 in Postmenopausal Women With Osteoporosis
07 juil. 2020 08h30 HE
|
Entera Bio Ltd.
‒ Institutional Review Boards (IRBs) Approve Amended Phase 2 Protocol with Newly Enrolled Patients Receiving a 2.5 mg Dose, 1.5 mg Dose, or Placebo ‒ ‒ Company Continues to Expect Completion of...
Annovis Bio Receives Institutional Review Board Approval to Initiate 15 Site Phase 2 Study in 68 Parkinson’s and Alzheimer’s Patients
07 juil. 2020 06h45 HE
|
Annovis Bio Inc.
BERWYN, Pa., July 07, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other...
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
17 juin 2020 07h30 HE
|
Innovation Pharmaceuticals Inc.
Data From Ongoing Testing at U.S. Regional Biocontainment Laboratory Data adds to growing body of research in both human and animal cell lines supporting Brilacidin’s robust antiviral properties...
Phathom Pharmaceuticals Provides Clinical Trial Status Update
15 juin 2020 08h30 HE
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., June 15, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
Axiom Exhibiting at DIA 2020 Global Annual Meeting and Virtual Conference June 14-18, 2020
12 juin 2020 15h06 HE
|
Axiom Real-Time Metrics Inc
TORONTO, June 12, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, will be a virtual exhibitor and have several delegates...
Axiom an Active Participant at BIO Digital International Convention 2020
08 juin 2020 12h18 HE
|
Axiom Real-Time Metrics Inc
TORONTO, June 08, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will have a significant delegate presence, be presenting,...
Cognition Therapeutics Receives $75.8 Million NIA Grant for 540-Patient Phase 2 Study of CT1812 in Collaboration with the Alzheimer's Clinical Trials Consortium
08 juin 2020 08h15 HE
|
Cognition Therapeutics, Inc.
New York, June 08, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease...
Clinical Trial Materials and Supplies Market Worth $25.9 Billion by 2027, Growing at a CAGR of 6% from 2019- Exclusive Report by Meticulous Research®
05 juin 2020 08h16 HE
|
Meticulous Market Research Pvt. Ltd.
London, June 05, 2020 (GLOBE NEWSWIRE) -- Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the...